Establishment of a bioassay model for lung cancer chemoprevention initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice

Experimental and Toxicologic Pathology

Volumn 60, Issue 6, 2008, Pages 469-473

  Yokohira, Masanao ^a   Takeuchi, Hijiri ^a   Saoo, Kousuke ^a   Matsuda, Yoko ^a   Yamakawa, Keiko ^a   Hosokawa, Kyoko ^a   Kuno, Toshiya ^a   Imaida, Katsumi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

8 MOP; A J mouse; Bioassay model; Chemoprevention; Lung cancer; NNK

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; METHOXSALEN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CARCINOGENESIS; CHEMOPROPHYLAXIS; FEMALE; HYPERPLASIA; LUNG ADENOMA; LUNG CANCER; MOUSE; NONHUMAN;

ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HYPERPLASIA; INJECTIONS, INTRAPERITONEAL; LUNG NEOPLASMS; MICE; MICE, INBRED A; NITROSAMINES; TIME FACTORS;

MUS;

EID: 49949109917     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.05.007     Document Type: Article

References (27)

1. Belinsky S.A., Devereux T.R., Foley J.F., Maronpot R.R., and Anderson M.W. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res 52 (1992) 3164-3173
2. Chung E.L. Chemoprevention of lung cancer by isothiocyanates and their conjugates in A/J mouse. Exp Lung Res 27 (2001) 319-330
3. Draper A.J., Madan A., and Parkinson A. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch Biochem Biophys 341 (1997) 47-61
4. Dungworth D.L., Rittinghausen S., Schwartz L., Harkema J.R., Hayashi Y., Kittel B., et al. Respiratory system and methothelium: lung (2001), WHO/IARC, Lyon
5. Fujita K., Nakayama K., Yamazaki Y., Tsuruma K., Yamada M., Nohmi T., et al. Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase. Environ Mol Mutagen 38 (2001) 329-338
6. Hasegawa R., Futakuchi M., Mizoguchi Y., Yamaguchi T., Shirai T., Ito N., et al. Studies of initiation and promotion of carcinogenesis by N-nitroso compounds. Cancer Lett 123 (1998) 185-191
7. Imaida K., Yokohira M., and Kuno T. Detection of carcinogenic and modifying potentials by test compounds using a mouse lung carcinogenesis bioassay. J Toxicol Pathol 20 (2007) 117-123
8. Ito N., Tatematsu M., Nakanishi K., Hasegawa R., Takano T., Imaida K., et al. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. Gann 71 (1980) 832-842
9. Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium-term bioassay system. Carcinogenesis 9 (1988) 387-394
10. Ito N., Hasegawa R., Imaida K., Hirose M., and Shirai T. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp Toxicol Pathol 48 (1996) 113-119
11. Kawano R., Takeshima Y., and Inai K. Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice. Jpn J Cancer Res 87 (1996) 44-50
12. Kitahashi T., Takahashi M., Yamada Y., Oghiso Y., Yokohira M., Imaida K., et al. Occurrence of mutations in the epidermal growth factor receptor gene in X-ray-induced rat lung tumors. Cancer Sci 99 (2008) 241-245
13. Kushida H., Fujita K., Suzuki A., Yamada M., Endo T., Nohmi T., et al. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis 21 (2000) 1227-1232
14. Lee H.Y., Oh S.H., Woo J.K., Kim W.Y., Van Pelt C.S., Price R.E., et al. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. J Natl Cancer Inst 97 (2005) 1695-1699
15. Li L., Xie Y., El-Sayed W.M., Szakacs J.G., Franklin M.R., and Roberts J.C. Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse. J Biochem Mol Toxicol 19 (2005) 396-405
16. Messina E.S., Tyndale R.F., and Sellers E.M. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 282 (1997) 1608-1614
17. Mitchell E., and Sanders J. Tobacco control in NSW: evidence supporting improved strategies to reduce exposure to environmental tobacco smoke. NSW Public Health Bull 13 (2002) 215-217
18. Miyazaki M., Yamazaki H., Takeuchi H., Saoo K., Yokohira M., Masumura K., et al. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas. Carcinogenesis 26 (2005) 1947-1955
19. Ono S., Hatanaka T., Hotta H., Satoh T., Gonzalez F.J., and Tsutsui M. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26 (1996) 681-693
20. Pereira M.A., Kramer P.M., Nines R., Liu Y., Alyaqoub F.S., Gunning W.T., et al. Prevention of mouse lung tumors by targretin. Int J Cancer 118 (2006) 2359-2362
21. Sakai H., Tsukamoto T., Yamamoto M., Shirai N., Iidaka T., Yanai T., et al. Differential effects of partial hepatectomy and carbon tetrachloride administration on induction of liver cell foci in a model for detection of initiation activity. Jpn J Cancer Res 92 (2001) 1018-1025
22. Takeuchi H., Saoo K., Yokohira M., Ikeda M., Maeta H., Miyazaki M., et al. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res 63 (2003) 7581-7583
23. Takeuchi H., Saoo K., Matsuda Y., Yokohira M., Yamakawa K., Zeng Y., et al. Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice. Cancer Lett 234 (2006) 232-238
24. Tatematsu M., Hasegawa R., Imaida K., Tsuda H., and Ito N. Survey of various chemicals for initiating and promoting activities in a short-term in vivo system based on generation of hyperplastic liver nodules in rats. Carcinogenesis 4 (1983) 381-386
25. Tsuda H., Lee G., and Farber E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res 40 (1980) 1157-1164
26. Yang G., Wang Z.Y., Kim S., Liao J., Seril D.N., Chen X., et al. Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice. Cancer Res 57 (1997) 1889-1894
27. Yang G.Y., Liu Z., Seril D.N., Liao J., Ding W., Kim S., et al. Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. Carcinogenesis 18 (1997) 2361-2365